| 标题： | 儿童超说明书用药管理指南（2021） |
| title： | Guidelines for the management of off-label use of drugs for pediatrics (2021) |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 其他 |
| field： | Others |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 临床医生、药师，卫生管理人员等可能参与到儿童超说明书用药行为的人群。 |
| Guide users： | Clinicians, pharmacists, health administrators, and other people who may be participating in the off-label use of drugs for pediatrics. |
| 证据分级方法： | GRADE(Grading of Recommendations Assessment,Development and Evaluation) |
| Evidence grading method： | |
| 制定单位： | 国家儿童健康与疾病临床医学研究中心，重庆医科大学附属儿童医院 |
| Formulating unit： | National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University. |
| 注册时间： | 2021-04-13 |
| Registration time： | |
| 注册编号： | IPGRP-2021CN088 |
| Registration number： | |
| 指南制订的目的： | 目前，儿童可选择的药物远远不能满足现实的需要。基于现状，未来很长一段时间，儿童超说明书用药（off-label use，OL）是婴幼儿、儿童和青少年非常突出的全球公共卫生问题。践指南是临床医疗实践做出诊疗决策的重要依据，但是目前没有针对儿童超说明书用药的指南。 |
| Purpose of the guideline： | The drug options available to children is far from meeting realistic needs at present. Based on the situation, off-label use of drugs(OL) will be a prominent global public health problem for pediatrics for a long time. Guidelines play an important role in clinical practice decisions, but there are no guidelines for OL for pediatrics currently. Our aim is to develop a management guideline to regulate the use of OL in pediatric clinical practice. |
最新注册
